Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials

ID
34155811000001108
Therapeutic Moiety
Irinotecan pegylated liposomal
Name
Irinotecan pegylated liposomal 43mg/10ml dispersion for infusion vials
Abbreviated name
Irinotecan pegylated liposomal 43mg/10ml inf vials
Preferred name basis
rINN - Recommended International Non-proprietary
Date of name applicability
1 May 2021
Previous name
Irinotecan pegylated liposomal 43mg/10ml solution for infusion vials
Basis of previous name
rINN - Recommended International Non-proprietary
Prescribing status
Valid as a prescribable product
Dose form
Discrete
Unit dose form size
10.000
Unit dose form units
ml
Unit dose unit of measure
vial
Ingredients
Irinotecan sucrosofate salt pegylated liposomal
Form & Route
dispersioninfusion.intravenous
Drug formulations
Dispersion for infusion
Drug route
Intravenous
Control drug
No Controlled Drug Status